Aerie Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 62
Rang # Quantité totale PI 21 971
Note d'activité PI 2,4/5.0    37
Rang # Activité PI 20 371
Symbole boursier AERI (nasdaq)
ISIN US00771V1089
Capitalisation 575M  (USD)
Industrie Drug Manufacturers - Major
Secteur Healthcare

Brevets

Marques

0 0
21 0
41 0
0
 
Dernier brevet 2024 - Polymorphs of a jak1/tyk2 inhibi...
Premier brevet 2006 - Prodrug derivatives of acids usi...

Derniers inventions, produits et services

2024 Invention Polymorphs of a jak1/tyk2 inhibitor and uses thereof. Provided herein are solid forms, for exampl...
Invention Compounds and processes for the preparation of jak inhibitors. Described are improved processes f...
2023 Invention Azetidinyl pyrimidines and uses thereof as jak inhibitors. Provided herein are compounds useful a...
2022 Invention Ophthalmic pharmaceutical compositions and uses thereof. Provided herein are ophthalmic pharmaceu...
Invention Synthetic intermediates and improved processes for preparing rock inhibitors. Provided herein are...
Invention Janus kinase inhibiting pyrazole compounds and uses thereof. Provided herein are pyrazole compoun...
Invention Azetidinyl pyrimidines and uses thereof. Provided herein are azetidine pyrimidine compounds. In p...
Invention Pharmaceutical preparation. Provided herein are solid forms of alpha-(aminomethyl)-4-(hydroxymeth...
Invention Stable isoquinoline-corticosteroid conjugates and uses thereof. Provided herein are compounds and...
Invention Implant delivery device. Implant delivery devices, methods of device assembly and methods of usin...
2021 Invention Intraocular implant for drug delivery. A medical implant is disclosed. The medical implant includ...
Invention Treatments. Described herein are compounds, combinations of compounds, compositions, formulations...
Invention Pharmaceutical preparation. Provided herein are pharmaceutical preparations comprising an aqueous...
2020 Invention Heterobicyclic carboxamides and uses thereof. Provided herein are heterobicyclic cyclopropanecarb...
Invention Ophthalmic composition for treating dry eye and symptoms thereof. It is provided an ophthalmic c...
Invention Pharmaceutical compositions for treating ocular diseases or disorders. Provided herein are pharma...
Invention Thienyl cyclopropyl-amino-isoquinolinyl amide compounds. Provided herein are thienyl cyclopropyl-...
Invention Compounds, compositions and methods for treatment of myopia. Provided herein are 8-methyl-8-azabi...
2019 Invention Aryl cyclopropyl-amino-isoquinolinyl amide compounds. Provided herein are amino isoquinolinyl ami...
Invention Isoquinoline-steroid conjugates and uses thereof. Provided herein are compounds and pharmaceutica...
Invention Mono-(acid) salts of 6-aminoisoquinolines and uses thereof. Provided herein are mono-(acid) salts...
Invention Amino-benzoisothiazole and amino-benzoisothiadiazole amide compounds. Provided herein are amino-b...
2018 Invention Aryl cyclopropyl-amino-isoquinolinyl amide compounds. Provided herein are arylcyclopropyl amino-i...
2017 Invention Methods for the preparation of 6-aminoisoquinoline. Described are methods for the preparation of ...
Invention Implant applicators. An intracameral injector needle having a substantially cylindrical body defi...
Invention Ophthalmic compositions. The present disclosure provides an ophthalmic composition comprising 4-(...
Invention Beta-amino-isoquinolinyl amide compounds. Disclosed are alpha-axyl-beta-axmno isoquinoline amide ...
2016 Invention Intravitreal drug delivery systems for the treatment of ocular conditions. The disclosure teaches...
Invention Ocular protein delivery. The disclosure teaches methods of making ocular, sustained release pharm...
Invention Implant applicators and methods of administering implants. Embodiments described herein relate ge...
2015 Invention Process for the preparation of kinase inhibitors and intermediates thereof. Described are process...
2014 Invention Isoquinoline compounds for the treatment of ocular diseases. Described herein are compounds and c...
Invention Combination therapy. Described herein are compounds and compositions for treating glaucoma and/or...
2011 Invention Drug delivery devices for delivery of ocular therapeutic agents. Drug delivery devices comprisin...